Tag Archives: AIMT

Top 10 Heal Care Stocks To Invest In Right Now

Celgene Corp. (NASDAQ:CELG) investors would probably like a few do-overs given the company’s stumbles over the past year. First, it suffered a key clinical-trial failure that forced it to ratchet back its long-term sales outlook. Then, the FDA sent it an embarrassing Refusal to File letter for its most-anticipated drug, ozanimod.

The setbacks have increased the pressure on the company to deliver a win, and fortunately, that win came in the form of positive pivotal-stage trial results for luspatercept, a drug that Celgene has licensed from Acceleron Pharma (NASDAQ:XLRN). On Thursday, the companies announced that luspatercept’s late-stage study in myelodysplastic syndromes (MDS) panned out, clearing the way for filings for approval next year. How big is this win for Celgene?

What’s going on

Luspatercept addresses chronic anemia in MDS by promoting the production of healthy red blood cells and regulating TGF-beta proteins involved in the late stages of creating red blood cells.

Top 10 Heal Care Stocks To Invest In Right Now: Computer Programs and Systems Inc.(CPSI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Millrace Asset Group Inc. acquired a new position in shares of Computer Programs & Systems, Inc. (NASDAQ:CPSI) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 45,000 shares of the company’s stock, valued at approximately $1,314,000. Millrace Asset Group Inc. owned about 0.32% of Computer Programs & Systems at the end of the most recent quarter.

  • [By Max Byerly]

    Computer Programs & Systems, Inc. (NASDAQ:CPSI) has received an average rating of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, one has given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $30.80.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Computer Programs & Systems (CPSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Computer Programs & Systems (NASDAQ: CPSI) and Perion Network Ltd Common Stock (NASDAQ:PERI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Top 10 Heal Care Stocks To Invest In Right Now: RPX Corporation(RPXC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Research Frontiers (NASDAQ: REFR) and RPX (NASDAQ:RPXC) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

  • [By Logan Wallace]

    Thompson Siegel & Walmsley LLC lifted its position in RPX Co. (NASDAQ:RPXC) by 32.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 787,377 shares of the business services provider’s stock after purchasing an additional 192,430 shares during the period. Thompson Siegel & Walmsley LLC owned about 1.58% of RPX worth $8,417,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    RPX (NASDAQ:RPXC) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday.

  • [By Dan Caplinger]

    Patent litigation abuse is a major problem in the tech industry, and policymakers have looked for ways to fight it. RPX (NASDAQ:RPXC) came up with a unique approach to patent protection involving purchases of various intellectual property to deter would-be plaintiffs from challenging ownership. Yet the market for those services hasn’t grown the way some had anticipated, and even after diversifying into legal discovery services, RPX saw little choice but to start pursuing strategic alternatives to come up with a future direction for its business.

Top 10 Heal Care Stocks To Invest In Right Now: Hertz Global Holdings Inc(HTZ)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news stories that may have effected Accern’s rankings:

    Get Hertz Global alerts:

    Trending Most Active Stock: Hertz Global Holdings, Inc. (HTZ) (nasdaqplace.com) Why is the 200 Simple Moving Average (SMA) so common for traders and analysts? Novavax, Inc. (NASDAQ:NVAX … (thestreetpoint.com) Hertz Global Holdings, Inc. (HTZ): That’s where you can keep the ball in your court (fintelegraph.com) Is Hertz Global Holdings Inc (NYSE:HTZ) A Financially Sound Company? (finance.yahoo.com) Hertz Global Hol Rises 1.95% on Heavy Volume: Watch For Potential Pullback (mysmartrend.com)

    A number of brokerages have commented on HTZ. ValuEngine upgraded shares of Hertz Global from a “hold” rating to a “buy” rating in a report on Thursday, June 7th. Zacks Investment Research downgraded shares of Hertz Global from a “hold” rating to a “sell” rating in a report on Tuesday, May 15th. Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $15.71.

  • [By Demitrios Kalogeropoulos]

    Hertz Global Holdings(NYSE:HTZ) shed 31% last month compared to a 2% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Dan Caplinger]

    Wall Street had another good session on Tuesday, with favorable earnings reports from some of the nation’s most successful technology companies helping to lift major benchmarks by 1% or more. Investors haven’t forgotten about some of the potential pitfalls that could derail the recovery, including both geopolitical and macroeconomic concerns. Yet traders seem to want to see the market test its all-time highs before deciding whether the correction could turn into a full-fledged bear market reversal. Some individual stocks, however, missed out on the good times. GoPro (NASDAQ:GPRO), Apellis Pharmaceuticals (NASDAQ:APLS), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern’s rankings:

    Get Hertz Global alerts:

    Hertz Global Holdings, Inc (HTZ) CFO Thomas C. Kennedy Buys 15,000 Shares (americanbankingnews.com) Northcoast Research Weighs in on Hertz Global Holdings, Inc’s Q2 2018 Earnings (HTZ) (americanbankingnews.com) Hertz Global Target of Unusually High Options Trading (HTZ) (americanbankingnews.com) Edited Transcript of HTZ earnings conference call or presentation 8-May-18 12:00pm GMT (finance.yahoo.com) Hertz Sweeps 2018 FlyerTalk Awards (finance.yahoo.com)

    Several equities research analysts have issued reports on HTZ shares. Zacks Investment Research upgraded Hertz Global from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Macquarie upgraded Hertz Global from a “neutral” rating to an “outperform” rating in a research report on Thursday, January 18th. Goldman Sachs dropped their target price on Hertz Global from $15.00 to $13.00 and set a “sell” rating on the stock in a research report on Thursday, February 15th. Finally, ValuEngine downgraded Hertz Global from a “hold” rating to a “sell” rating in a research report on Thursday, February 15th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $15.71.

Top 10 Heal Care Stocks To Invest In Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After disclosing that the Food and Drug Administration is asking for more information before signing off on a phase 1 study of its “Sleeping Beauty” CAR-T for leukemia and lymphoma, shares in Ziopharm Oncology (NASDAQ:ZIOP) were tumbling 17.7% at 3 p.m. EDT today.

  • [By George Budwell]

    Shares of the clinical-stage biotech Ziopharm Oncology (NASDAQ:ZIOP) rose by a healthy 16% last month,according toS&P Global Market Intelligence. What sparked this sizable rally?

  • [By Keith Speights]

    If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm’s share price has dropped more than 25% so far in 2018, while Celldex stock has plunged more than 80%.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top 10 Heal Care Stocks To Invest In Right Now: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday was a calm day on Wall Street, with several major benchmarks posting modest gains while others stayed closer to the unchanged mark. Market participants generally seemed ready to take a pause in trends over the past several days, as crude oil prices bounced back from their recent drop to climb above $65 per barrel while interest rates eased slightly lower. Yet despite a resilient market that largely avoided most downward pressure, some individual stocks weren’t as lucky. Carnival (NYSE:CCL) (NYSE:CUK), Tarena International (NASDAQ:TEDU), and Genesco (NYSE:GCO) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results.

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Logan Wallace]

    Tarena International (NASDAQ: TEDU) and Aspen Group (NASDAQ:ASPU) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

  • [By Ethan Ryder]

    Tarena International (NASDAQ: TEDU) and TAL Education (NYSE:TAL) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Top 10 Heal Care Stocks To Invest In Right Now: Leggett & Platt, Incorporated(LEG)

Advisors’ Opinion:

  • [By Logan Wallace]

    California Public Employees Retirement System boosted its stake in shares of Leggett & Platt, Inc. (NYSE:LEG) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 413,255 shares of the company’s stock after purchasing an additional 10,689 shares during the period. California Public Employees Retirement System owned about 0.31% of Leggett & Platt worth $18,332,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Leggett & Platt (NYSE: LEG) and Hooker Furniture (NASDAQ:HOFT) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Leggett & Platt (LEG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Candriam Luxembourg S.C.A. decreased its position in shares of Leggett & Platt, Inc. (NYSE:LEG) by 7.6% in the 1st quarter, HoldingsChannel reports. The fund owned 39,994 shares of the company’s stock after selling 3,289 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Leggett & Platt were worth $1,774,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Shares of LEG Immobilien AG (FRA:LEG) have been assigned an average rating of “Buy” from the nineteen research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is €101.62 ($118.16).

Top 10 Heal Care Stocks To Invest In Right Now: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Shane Hupp]

    Aimmune Therapeutics (NASDAQ:AIMT)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Wednesday. They currently have a $72.00 target price on the biotechnology company’s stock. Wedbush’s price objective points to a potential upside of 117.59% from the company’s previous close.

  • [By ]

    Aimmune Therapeutics (AIMT) : “I do like it. That’s an important niche business. “

    Ingersoll-Rand (IR) : “I like Ingersoll-Rand. They work well at this phase in the cycle.”

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.13, with a consensus price target of $55.50 and a 52-week range of $15.97 to $40.65.

  • [By ]

    In the Lightning Round, Cramer was bullish on Ingersoll-Rand (IR) , The Blackstone Group (BX) , Thermo Fisher Scientific (TMO) , FMC Corp (FMC) , Nike (NKE) , Zebra Technologies (ZBRA) and Aimmune Therapeutics (AIMT) .

Top 10 Heal Care Stocks To Invest In Right Now: Bravo Brio Restaurant Group Inc.(BBRG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media coverage about Bravo Brio Restaurant Group (NASDAQ:BBRG) has trended positive on Saturday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bravo Brio Restaurant Group earned a daily sentiment score of 0.39 on Accern’s scale. Accern also assigned media coverage about the restaurant operator an impact score of 45.847415840944 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Heal Care Stocks To Invest In Right Now: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania. “

  • [By Stephan Byrd]

    Headlines about Aclaris Therapeutics (NASDAQ:ACRS) have been trending somewhat positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aclaris Therapeutics earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the biotechnology company an impact score of 46.9638334424702 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Aclaris Therapeutics (NASDAQ:ACRS) received a $50.00 price target from equities research analysts at Cantor Fitzgerald in a report issued on Tuesday. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 177.62% from the company’s current price.

Top 10 Heal Care Stocks To Invest In Right Now: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cherokee (NASDAQ:CHKE) released its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.11), RTT News reports. Cherokee had a negative return on equity of 13.63% and a negative net margin of 130.24%. During the same quarter last year, the business posted ($0.07) earnings per share.

  • [By Garrett Baldwin]

    Following the June FOMC meeting, silver prices are hovering at very attractive price levels. With interest rates heading higher, it’s going to be a very good time for silver hounds to buy on the dip and deliver incredible profits in the months ahead.Learn more right here.

    The Top Stock Market Stories for Thursday
    On Thursday, the European Central Bank held its meeting in Latvia to discuss the future of its quantitative easing program. The central bank of the world’s largest economic bloc said that it will likely end its quantitative easing program in December. This represents an extension beyond the current plan to end the stimulus program in September. ECB President Mario Draghi said the program would be reduced to 15 billion euros each month during the final three months of the year. Yesterday, the U.S. Federal Reserve raised interest rates for the second time in 2018. The central bank said that economic growth has been rising at a solid rate and hinted that it could raise rates two more times this year. Fed Chair Jerome Powell did raise an alarm on Wednesday after stating that companies are holding back on investment due to ongoing concerns about U.S. President Donald Trump’s trade policies. Trump is expected to decide this week on whether to proceed with tariffs on about $50 billion in Chinese goods. Trade tensions are heating up again. This morning, China announced it would call off its deal to avoid a trade war if the Trump administration proceeds with tariffs on Friday morning. Tomorrow, the Trump team will decide if it will hit China with tariffs on roughly $50 billion in goods.
    Stocks to Watch Today: ADBE, CMCSA, TSLA, MSFT
    Adobe Systems Inc. (Nasdaq: ADBE) will report earnings after the bell Thursday. The software giant is expected to report earnings per share of $1.54 on top of $2.15 billion in revenue. Insider buying is alive and well at Tesla Inc. (Nasdaq: TSLA). Chair and CEO Elon Musk purchased $25 million in company stock, according to a

  • [By Max Byerly]

    Cherokee (NASDAQ: CHKE) and J.Jill (NYSE:JILL) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Hot Undervalued Stocks To Own Right Now

Description of the opportunity and investment thesis

CRHM represents a compelling risk/reward opportunity in the form of a rapidly growing leader in anesthesiology services for GIs in the US and Canada. We believe the company is undervalued on an absolute and relative basis, currently trading at a dramatically low multiple of current and future estimated free cash flow. Given the companys niche position in their market, stable business model, long runway for growth, and fears surrounding short-term operational results, we feel weve been provided with a solid margin of safety at current price levels, with the chance for 100% upside or more within 12-18 months.

Hot Undervalued Stocks To Own Right Now: Blackrock Global(BOE)

Advisors’ Opinion:

  • [By Robert Rapier]

    Whiting Petroleum (WLL) is one of Continental’s biggest competitors in the Bakken. Whiting is the second-largest oil producer in North Dakota, averaging 82,500 barrels of oil equivalent (BOE) of production in 2012, across more than 700,000 acres of leased land.

Hot Undervalued Stocks To Own Right Now: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    Consumers across the nation know Flowers Foods (NYSE:FLO) from its Wonder bread, Tastykake snack cakes, and Nature’s Own bakery brands. Yet the truly novel thing about Flowers is how it has done such a good job of building up a national presence in an industry that is typically dominated by local competition. Coming into Monday’s fourth-quarter financial report, Flowers investors were hoping to see at least some growth in sales and earnings, but the bakery company wasn’t able to deliver the pace of expansion that most shareholders really want to see.

Hot Undervalued Stocks To Own Right Now: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Hot Undervalued Stocks To Own Right Now: WD-40 Company(WDFC)

Advisors’ Opinion:

  • [By Monica Gerson]

    WD-40 Company (NASDAQ: WDFC) is projected to post its quarterly earnings at $0.86 per share on revenue of $99.10 million.

    Hooker Furniture Corporation (NASDAQ: HOFT) is estimated to report its quarterly earnings at $0.40 per share on revenue of $62.20 million.

  • [By Monica Gerson]

    WD-40 Company (NASDAQ: WDFC) reported better-than-expected earnings for its second quarter, but the company missed analysts’ sales estimates. WD-40 shares fell 0.97 percent to $106.00 in the after-hours trading session.

Hot Undervalued Stocks To Own Right Now: Smith & Nephew SNATS, Inc.(SNN)

Advisors’ Opinion:

  • [By Charles Carlson, CEO and Portfolio Manager, Horizon Investment Services]

    For investors looking for growth but also income, I especially like three health-care related stocksFresenius Medical (FMS), Novo Nordisk (NVO), and Smith & Nephew (SNN).

Hot Undervalued Stocks To Own Right Now: Nuance Communications Inc.(NUAN)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about high options activity in Nuance Communications Inc. (NASDAQ: NUAN). Traders were buying the June 19 calls for $1. The trade breaks even at $20 or 2.20 percent above the closing price on Wednesday. Najarian followed the trade and he is going to hold the position for two weeks.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about unusually high options activity in Nuance Communications Inc. (NASDAQ: NUAN).

  • [By Lisa Levin]

    Shares of Nuance Communications Inc. (NASDAQ: NUAN) got a boost, shooting up 10 percent to $17.05 after the company posted better-than-expected Q4 earnings. Raymond James upgraded Nuance Communications from Outperform to Strong Buy.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to

Top 10 Performing Stocks To Watch For 2018

As the end of the year nears, companies will start to report their end of the year numbers giving investors the opportunity to find value for their portfolios in 2017. Earlier this week, Nordson Corporation (NASDAQ:NDSN) released its numbers for the fourth quarter of its 2016 fiscal year. The machinery company, with market capitalization of just under $6.00 billion, specializes in a variety of manufacturing technologies across its segments, Adhesive Dispensing Systems, Advanced Technology Systems, and Industrial Coating Systems. After its fourth quarter earnings report, NDSN may have proven that it has the right value for a long-term play in an overbought market.

According to prices on December 14th, NDSN is up almost 80 percent year to date compared to the S&P 500 ETF’s (NYSEARCA:SPY) gain of about 14 percent. The stock has made a bullish run off of three solid earnings reports earlier in 2016, each boosting share prices by about 10 percent. As a mid-cap stock, it’s proven to be a more worthy growth stock as well, outperforming the S&P Mid-cap 400 which has grown by just over 20 percent this year. Currently, the stock is trading at all-time highs caused by bullish momentum from the so called “Trump Rally.” Another rally spurred by the recent earnings numbers could push NDSN even higher as investors opt for a position in the machinery company. How solid is this company? And do the fundamentals justify the technical strength the stock is showing?

Top 10 Performing Stocks To Watch For 2018: Siebert Financial Corp.(SIEB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap discount brokerageSiebert Financial Corp (NASDAQ: SIEB):

    Siebert Financial has been on our watchlist for a while, overbought and toying with the idea of a pullback. We’re finally starting to see evidence that the weight of the gain is taking a toll. We’ve seen a string of lower highs following the last bullish gasp from the 9th. We’re going to assume that was the pivot point. (It has been so far, anyway.)

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

  • [By Lisa Levin]

    Siebert Financial Corp. (NASDAQ: SIEB) shares shot up 61 percent to $8.30 following news it will offer deeply discounted online trading of U.S. equities next year.

  • [By Cameron Saucier]

    Siebert (Nasdaq: SIEB) is a holding company that has a retail discount brokerage business through its subsidiary, Muriel Siebert & Co. SIEB rose 60% last month after it announced a purchasing agreement with Kennedy Cabot Acquisition. Under the agreement, Kennedy Cabot will purchase shares of SIEB. SIEB is currently trading at $3.37 per share and is up 157% YOY.

Top 10 Performing Stocks To Watch For 2018: Nestl茅 S.A. (NSRGF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In sum, the three companies are equally valued at generous multiples. It is difficult to choose one of them based on fundamentals or valuations, but we like the strategy of Nestl茅 and P&G more than Unilever. Therefore, we recommend investing in these companies only if someone is interested in a limited but relatively safe upside potential. Good entry prices would be as follows: Nestl茅 (OTCPK:NSRGF) at CHF 70.1 or $70.1 for the ADR , P&G at $83.6 and Unilever (OTC:UNLVF) at 34.1 or $38 for the ADR (NYSE:UN).

  • [By SEEKINGALPHA.COM]

    A recently updated map from HowMuch.net ranking the world’s most valuable brands by country in 2017 shows that Apple Inc. (AAPL) lost its spot as the US’s most valuable brand. Of these, the top 10 most valuable brands with shares or ADRs traded in the US are:

    US-based search engine and Google parent Alphabet Inc (GOOG) (NASDAQ:GOOGL) Swiss food giant Nestle (OTCPK:NSRGF) Korea’s Samsung Electronics (OTC:SSNLF) – part of a larger group of Samsung brands China’s (and the world’s) largest bank ICBC (OTCPK:IDCBF) Japanese automaker Toyota (TM) Irish medical equipment maker Medtronic (MDT) Royal Dutch Shell, the oil company (RDS.A) Royal Bank of Canada (RY) Spanish bank Santander (SAN), and Hong Kong-based insurer AIA (OTCPK:AAGIY)

    In 11th and 12 place, by market cap, are British telecom Vodafone Plc (VOD) and German automaker BMW (OTCPK:BMWYY), whose brands are valued at 2-4x AIA’s according the map, but whose market caps trade at significantly lower multiples in the current market environment.

Top 10 Performing Stocks To Watch For 2018: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Sohu.com Inc (NASDAQ: SOHU) shares were also up, gaining 14 percent to $57.89. Sohu.com reported a Q2 loss of $1.85 per share on revenue of $461.168 million.

  • [By R. Chandrasekaran]

    The following stocks are rated Underweight:

    Baidu. Sohu.com Inc (NASDAQ: SOHU).

    Full ratings data available on Benzinga Pro.

    Do you have ideas for articles/interviews you’d like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

  • [By Belinda Cao]

    Sohu.com Inc. (SOHU), which sold a stake in its search unit to Tencent Holdings Ltd. (700), advanced 11 percent for the week to $72.06. It retreated 5.9 percent Sept. 20. Tencent, Chinas biggest Internet company by market value, paid $448 million for a 36.5 percent stake in Sohus Sogou unit last week and merge its own search service with Sogou.

  • [By Matthew Smith]

    Shares in Sohu.com (SOHU) continued their rapid rise, hitting yet another fresh 52-week high during the session, as the company announced the special dividend from Sohou yesterday (press release located here). Sohu.com will receive nearly $161.2 million in the transaction which is part of the overall $400 million deal with Tencent (TCEHY.PK) which was announced not too long ago. These are exciting times in the internet space as we move from computers to mobile devices, but China’s internet landscape looks like the ‘Wild West’ right now and we expect to see further deals as companies jockey for position in their respective niches and consolidation begins as the larger players look to step up growth and gain exposure to new business segments.

  • [By Wayne Duggan]

    Sogou is Baidu’s biggest rival when it comes to mobile search engine market share. The app is owned by Sohu.com Inc (NASDAQ: SOHU), and its position as second fiddle to Baidu makes it most similar to Microsoft Corporation (NASDAQ: MSFT)’s Bing.

  • [By Roberto Pedone]

    Sohu.com (SOHU) is a Chinese online media, search, gaming, community and mobile service group. This stock closed up 7.5% to $69.61 in Monday’s trading session.

    Monday’s Volume: 4.90 million

    Three-Month Average Volume: 1.01 million

    Volume % Change: 351%

    From a technical perspective, SOHU ripped sharply higher here with heavy upside volume. This move pushed shares of SOHU into breakout territory, since the stock took out some near-term overhead resistance at $67.80. Shares of SOHU are now quickly moving within range of triggering another breakout trade. That trade will hit if SOHU manages to take out Monday’s high of $69.71 to its 52-week high at $70.63 with high volume.

    Traders should now look for long-biased trades in SOHU as long as it’s trending above Monday’s low of $66.95 or above that first breakout level of $67.80 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.01 million shares. If that breakout hits soon, then SOHU will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $75 to $80.

Top 10 Performing Stocks To Watch For 2018: FLIR Systems, Inc.(FLIR)

Advisors’ Opinion:

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

  • [By Teresa Rivas]

    Flir Systems(FLIR) was the biggest loser in the S&P 500 on Tuesday, but the stock recouped all its losses Wednesday, and then some.

    Getty Images

    Flir Systems gained $2.78, or 8.1%, to close at $36.93.

    The company’sdisappointing fourth-quarter earnings report was forgotten when it announced that the U.S. Coast Guard awarded it a $50 million contract. Flir will provide marine electronics systems for more than 2,000 Coast Guard vessels for its Scalable Integrated Navigation Systems 2 (SINS-2) program over a five-year period, with the option for extended delivery for an additional five years.

    Even before the news, Imperial Capital’sEd Mally was bullish on the stock’s prospects, who raised his price target on the stock by $2, to $38:

    Although we believe that some may still consider Flir as just a premier provider of very high-end cameras in the bellies of Bell Helicopters or border towers in a lumpy government sector, this 35-year-old company is a global leader in thousands of infrared detector cores and thermography equipment markets and also provides lower priced products to commercial and consumer security customers as well as other customers.

    Flir is up 2% so far this year.

    Coty(COTY) was the hottest stock in the S&P 500 yesterday.

Top 10 Performing Stocks To Watch For 2018: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Keith Speights]

    There are several choices for investing in HIV drug stocks. Three of the best options for long-term investors are Gilead Sciences (NASDAQ:GILD), GlaxoSmithKline (NYSE:GSK), and Merck (NYSE:MRK). Here’s why these HIV drug stocks could be solid picks in 2017.

  • [By Sean Williams]

    Third, in late March, Mylan announced that the Food and Drug Administration had rejected its application to market a generic version of GlaxoSmithKline’s (NYSE:GSK) blockbuster asthma and COPD inhalable drug, Advair. GlaxoSmithKline’s Advair lost patent protection more than six years ago, but only within the past couple of years did the FDA lay out a course for generic drug producers to follow in order to get a generic version of the drug approved. Meanwhile, Glaxo still enjoys blockbuster sales of Advair as generic versions of the drug have yet to hit the market.

  • [By WWW.MONEYSHOW.COM]

    Two of our top holdings, GlaxoSmithKline (GSK) and Merck (MRK) have seen substantial improvement in earnings as new drugs start to build market share. Glaxo and Merck offer dividend yields of 4.71% and 3.08%, respectively.

  • [By Paul Ausick]

    GlaxoSmithKline plc (NYSE: GSK) dropped about 1% Wednesday to post a new 52-week low of $34.52 after closing at $34.86 on Tuesday. The stock’s 52-week high is $44.54. Volume of around 4.8 million was about equal to the daily average. The company’s HIV drug is being challenged by a potentially better drug from competitor Gilead Sciences.

Top 10 Performing Stocks To Watch For 2018: Radiant Logistics, Inc.(RLGT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Lithia Motors Inc (NYSE: LAD) and Radiant Logistics Inc (NYSE: RLGT).

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    United Natural Foods, Inc. (NASDAQ: UNFI) reported better-than-expected earnings for its fourth quarter on Monday. United Natural Foods shares gained 1.51 percent to $42.45 in the after-hours trading session.
    Wall Street expects Radiant Logistics Inc (NYSE: RLGT) to post quarterly earnings at $0.03 per share on revenue of $202.06 million after the closing bell. Radiant Logistics shares rose 3.68 percent to close at $3.10 on Monday.
    Anadarko Petroleum Corporation (NYSE: APC) announced the acquisition of Freeport-McMoRan Inc (NYSE: FCX)’s deepwater Gulf of Mexico assets for $2 billion. The company also reported an offering of 35.25 million shares of common stock. Anadarko Petroleum shares dropped 2.92 percent to $56.10 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Performing Stocks To Watch For 2018: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) lost nearly 2.7% Friday to post a new 52-week low of $42.25 after closing Thursday at $43.41. The 52-week high is $55.94. Volume of around 6.7 million was nearly 3 times the daily average of around 2.6 million shares traded. The data research and information company had no specific news Friday.

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) dropped about 1.5% Thursday to post a new 52-week low of $40.97 after closing Wednesday at $41.59. The 52-week high is $55.94. Volume of around 5.2 million was about 70% above the daily average of around 3.2 million shares traded. The company had no specific news Thursday.

Top 10 Performing Stocks To Watch For 2018: Duluth Holdings Inc.(DLTH)

Advisors’ Opinion:

  • [By Jason Hall, Travis Hoium, and Brian Feroldi]

    In our ongoing search for just such quality growth stocks, we asked three of our contributors to pick out ones they think have high growth potential from here, and tell us why. They gave us a unique retailer that’s carving out a huge following in Duluth Holdings(NASDAQ:DLTH), a recovering fast-casual dining darling inChipotle Mexican Grill (NYSE:CMG), and a gaming and resorts giant,Wynn Resorts (NASDAQ:WYNN).

  • [By Monica Gerson]

    Duluth Holdings Inc (NASDAQ: DLTH) is projected to post its quarterly earnings at $0.28 per share on revenue of $133.21 million.

    DBV Technologies SA ADR (NASDAQ: DBVT) is expected to post a quarterly loss at $0.60 per share.

  • [By Lisa Levin]

    Duluth Holdings Inc (NASDAQ: DLTH) shares were also up, gaining 23 percent to $21.94 as the company reported upbeat results for its fourth quarter on Thursday.

  • [By Monica Gerson] Related DLTH After-Hours Recap: CarMax, Wynn, Relypsa, ConAgra, Ruby Tuesday & More Earnings Scheduled For April 7, 2016 Duluth Holdings' (DLTH) CEO Stephanie Pugliese on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha)
    Related GPS After-Hours Recap: CarMax, Wynn, Relypsa, ConAgra, Ruby Tuesday & More Gap Comps Down 6% In March; Shares Plunge Difficult March Comparisons Were Too High For Retailers To Beat (Seeking Alpha)

    Some of the stocks that may grab investor focus today are:

Top 10 Performing Stocks To Watch For 2018: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

Top 10 Performing Stocks To Watch For 2018: Federal Agricultural Mortgage Corporation(AGM)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agri-Finance Companies

    Federal Agricultural Mortgage Corp. (NYSE: AGM): +233 percent since 2011.

    Notwithstanding the drought, seed companies and agri-produce companies have fared well. The performance of pesticide and fertilizer companies were mixed during the period.

stock market update

A few days ago, Baker Hughes (NYSE:BHI) came out with some data regarding the global rig count. During a time when oil production continues to fall in the U.S., as well as in other countries in the world like China and Venezuela, but prices are rising, fears are arising that the uptick in the rig count will result in more production coming on-line moving forward – which, if true, would prolong or maybe even worsen the oil market recovery. In what follows, I will dig into the data provided by the company and give my assessment of the overall market and what it means for investors in companies like Memorial Production Partners (NASDAQ:MEMP), Approach Resources (NASDAQ:AREX), and Legacy Reserves (NASDAQ:LGCY), as well as for the United States Oil ETF (NYSEARCA:USO) and other oil-related ETFs moving forward.

A disclosure

As a disclosure, I should mention that the recent monthly data provided by Baker Hughes pertaining to the rig count incorporates not only oil rigs, but natural gas rigs as well. As much as I wish that the data was broken down into both categories, that’s not how it’s presented. Having said that, this isn’t necessarily a problem, because in its Drilling Productivity Report, the EIA (Energy Information Administration) assumes that all rigs produce a blend of the two – so its own estimates look at the overall rig count, not rig counts that are divided.

stock market update: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

stock market update: Jewett-Cameron Trading Company(JCTCF)

Advisors’ Opinion:

  • [By Lisa Levin]

    Jewett-Cameron Trading Company Ltd (NASDAQ: JCTCF) shares shot up 11 percent to $13.35. Jewett-Cameron reported Q3 earnings of $0.53 per share on revenue of $16.7 million.

stock market update: Berkshire Hathaway Inc. (BRK-A)

Advisors’ Opinion:

  • [By Paul Ausick]

    Among other stories related to the company last week, Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) reported that it now owns about 57.4 million shares of Apple stock, up from 15.23 million at the end of the third quarter of 2016.

  • [By John Maxfield]

    Stocks are up across the board since the presidential election, boosting the value of Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) stock portfolio, but few stocks have rallied as much as Bank of America (NYSE:BAC).

  • [By Matthew Frankel]

    I won’t keep you in suspense — Warren Buffett-led Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) owns 400,000,000 shares of Coca-Cola (NYSE:KO), worth a total of $16.7 billion as of this writing. This translates to a 9.4% stake in the beverage giant, and makes Coca-Cola Buffett’s third-largest stock investment.

  • [By Jon C. Ogg]

    Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2016. Outside of WarrenBuffett being one of the richest men alive and being considered the greatest investor of modern times, there have been many key changes in the Buffett stocks over recent quarters.

stock market update: Honeywell International Inc.(HON)

Advisors’ Opinion:

  • [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
    Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
    Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
    General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
    Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
    Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
    Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
    SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
    ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
    Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
    Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
    WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
  • [By Ben Levisohn]

    Honeywell International (HON) is doing what its bigger industrial competitor General Electric (GE) can’t–beating earnings forecasts and seeing its shares gains.

    Getty Images

    Honeywell reported a profit of $1.66 a share, beating estimates for $1.62 a share, on sales of $9.49 billion, beating forecasts for $9.33 billion. Honeywell also lifted the bottom end of its full-year guidance range to $6.90, from $6.85.

    Vertical Research Partners’ Robert Stallard digs into Honeywell’s guidance:

    Honeywell continues to expect that the aftermarket in air transport (supported by 4-5% flight hour growth) will grow faster than at BGA (with declining flight hours in BGA expected). For bizjet, Honeywell reiterated that it isnt anticipating an OE recovery until the 2018/19 timeframe. It expects Q2 Aerospace sales to be flat to down 2% on the similar trends of air transport aftermarket growth being offset by ongoing softness in BGA and Space, and noted that Q2 should be the last quarter of OE incentive headwinds (H2 moving to a ~$70m tailwind versus a ~$25m headwind in H1).

    Shares of Honeywell have gained 2.6% to $126.96 at 2:54 p.m. today, while General Electric has fallen 1.9% to $29.70 after reporting earnings. The Industrial Select Sector SPDR ETF (XLI) has advanced 0.2% to $65.48.

  • [By Laurie Kulikowski]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Aerospace & Defense industry average. The net income increased by 8.3% when compared to the same quarter one year prior, going from $1,167.00 million to $1,264.00 million.

     

  • [By Paul Ausick]

    According to a report at Bloomberg News, some of the companies sending representatives along include General Electric Co. (NYSE: GE), Honeywell International Inc. (NYSE: HON), Boeing Co. (NYSE: BA), and Qualcomm Inc. (NASDAQ: QCOM). One company that has said it is not participating in the trip is Caterpillar Inc. (NYSE: CAT).

  • [By Laurie Kulikowski]

    HONEYWELL INTERNATIONAL INC has improved earnings per share by 8.8% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, HONEYWELL INTERNATIONAL INC increased its bottom line by earning $5.33 versus $4.92 in the prior year. This year, the market expects an improvement in earnings ($6.10 versus $5.33).

     

stock market timings

Related AAPL Nikkei: Apple Will Continue Reduced Production Of iPhones Goldman Says Apple, Seagate And Visa Options Are Underpricing Earnings Alpha My Dividend Growth Portfolio – Q1 2016 Summary (Seeking Alpha)
Related VRTX After-Hours Recap: CarMax, Wynn, Relypsa, ConAgra, Ruby Tuesday & More Benzinga's Top Initiations

Even though markets slipped on Friday, driven by tumbling oil prices and Apple Inc. (NASDAQ: AAPL)’s poor performance, major indexes were still up for the week.

stock market timings: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

stock market timings: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Castor believes the cash has disappeared into working capital, which has grown from 23% to more than 50% since 2008. Comparable company PrestigeBrand (PBH) uses 11%; Unilever(UL) and Colgate-Palmolive(CL) far less.

stock market timings: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Paul Ausick]

    It is not often that a secondary stock offering sends a companys shares higher, but we are seeing that very phenomenon Friday morning. Chinese solar PV maker JinkoSolar Holding Co. Ltd. (NYSE: JKS) and stock image company Shutterstock Inc. (NASDAQ: SSTK) both priced secondary offerings this morning and shares in both companies have risen sharply.

stock market timings: U.S. Auto Parts Network, Inc.(PRTS)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggestedshorting small cap online aftermarket auto parts stock U.S. Auto Parts Network, Inc (NASDAQ: PRTS):

  • [By Lisa Levin]

    In trading on Monday, cyclical consumer goods & services shares rose by just 0.1 percent. Meanwhile, top losers in the sector included U.S. Auto Parts Network, Inc. (NASDAQ: PRTS), down 22 percent, and Sears Holdings Corp (NASDAQ: SHLD), down 13 percent.